BML Capital Management as of Sept. 30, 2024
Portfolio Holdings for BML Capital Management
BML Capital Management holds 29 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ishares Tr 0-3 Mnth Treasry (SGOV) | 16.0 | $27M | 270k | 100.72 | |
| Instil Bio Com New (TIL) | 13.3 | $23M | 335k | 67.32 | |
| Atea Pharmaceuticals (AVIR) | 13.1 | $22M | 6.7M | 3.35 | |
| Aclaris Therapeutics (ACRS) | 9.6 | $16M | 14M | 1.15 | |
| Spdr Ser Tr Bloomberg 1-3 Mo (BIL) | 9.5 | $16M | 175k | 91.81 | |
| Adverum Biotechnologies Com New (ADVM) | 9.4 | $16M | 2.3M | 7.02 | |
| Tectonic Therapeutic (TECX) | 3.8 | $6.4M | 212k | 30.30 | |
| An2 Therapeutics (ANTX) | 3.6 | $6.2M | 5.7M | 1.07 | |
| Reneo Pharmaceuticals (RPHM) | 3.5 | $5.9M | 3.5M | 1.70 | |
| Oramed Pharmaceuticals Com New (ORMP) | 3.1 | $5.3M | 2.2M | 2.44 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 2.5 | $4.2M | 4.1M | 1.02 | |
| Aadi Bioscience (AADI) | 2.4 | $4.1M | 2.0M | 2.06 | |
| Connect Biopharma Hldgs Ads (CNTB) | 1.8 | $3.0M | 2.1M | 1.44 | |
| Pmv Pharmaceuticals (PMVP) | 1.5 | $2.5M | 1.7M | 1.49 | |
| Astrotech Corp (ASTC) | 1.0 | $1.8M | 220k | 7.99 | |
| Milestone Pharmaceuticals (MIST) | 1.0 | $1.7M | 1.1M | 1.52 | |
| Lenz Therapeutics (LENZ) | 0.8 | $1.4M | 60k | 23.74 | |
| Ikena Oncology (IKNA) | 0.7 | $1.3M | 723k | 1.73 | |
| Vanda Pharmaceuticals (VNDA) | 0.6 | $1.1M | 229k | 4.69 | |
| Lisata Therapeutics (LSTA) | 0.5 | $854k | 285k | 3.00 | |
| Pieris Pharmaceuticals Com New | 0.4 | $699k | 42k | 16.58 | |
| Calcimedica Com New (CALC) | 0.4 | $682k | 154k | 4.43 | |
| Allovir (ALVR) | 0.3 | $488k | 603k | 0.81 | |
| Talis Biomedical Corp Com New (TLIS) | 0.3 | $460k | 249k | 1.85 | |
| Vistagen Therapeutics Ord (VTGN) | 0.3 | $452k | 150k | 3.01 | |
| Forte Biosciences Com New (FBRX) | 0.2 | $394k | 71k | 5.59 | |
| Nextcure (NXTC) | 0.2 | $379k | 277k | 1.37 | |
| Verrica Pharmaceuticals (VRCA) | 0.2 | $261k | 180k | 1.45 | |
| Hillevax (HLVX) | 0.0 | $35k | 20k | 1.76 |
